Markey Cancer Center, Lexington Clinic renew cancer care agreement

Shot of the outside of the Markey Cancer Center in Lexington.

The University of Kentucky Markey Cancer Center and Lexington Clinic have renewed their agreement to provide cancer services through the Markey Cancer Center at Lexington Clinic, extending a collaboration that began in 2019.

Under the renewed agreement, Lexington Clinic physicians and providers continue to deliver cancer care at two locations: UK HealthCare Turfland, 2195 Harrodsburg Road in Lexington, and 2019 Corporate Drive in Richmond. Services include medical oncology, infusion and radiation therapy — complimenting the advanced cancer care provided at the UK Markey Cancer Center on the UK campus.

“Our collaboration reflects our shared commitment to deliver coordinated, patient-centered care,” said Rachel M. Harper, M.D., head of section, the Markey Cancer Center at Lexington Clinic. “By working together, we ensure patients benefit from both the personalized care of our providers and the leading-edge resources of an NCI-designated Comprehensive Cancer Center.”

The Markey Cancer Center at Lexington Clinic, a physician group consisting of three hematologists/medical oncologists, one medical oncologist and one APRN, now accounts for 7.9% of Markey’s nearly 5,500 annual cases. Lexington Clinic is the largest independent multi-specialty group practice in Central Kentucky, with providers in more than 40 specialties across more than 34 locations.

Through the collaboration, patients have access to the resources of a National Cancer Institute-designated Comprehensive Cancer Center, including specialty pharmacy services, supportive care services and the latest clinical trials. Markey is Kentucky’s only NCI-designated cancer center and one of 58 in the country to hold the NCI’s Comprehensive Cancer Center designation, the highest level of recognition a cancer center can achieve. Participation in clinical trials through the collaboration also supports Markey’s research mission, contributing to the development of new cancer treatments and therapies.

“Our goal has always been to make sure Kentuckians can get outstanding cancer care without having to travel far from home,” said UK Markey Cancer Center Director B. Mark Evers, M.D. “The Markey Cancer Center at Lexington Clinic is a strong example of how that works in practice, and we’re glad to continue this collaboration and expand access to care for patients across Central Kentucky.”

The renewed agreement is for three years through 2028.

This content was produced by UK HealthCare Brand Strategy.

Topics in this Story

  1. News and Events
  2. Cancer